A couple of ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 850,000 shares of Pacific Biosciences of California Inc. (NASDAQ: PACB) altogether on Monday, as the prices of these ETFs were up less than 1% in Monday’s session. These funds are up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 96,000 shares, while ARK Innovation ETF (NYSEARCA: ARKK) bought 756,850 shares. At Monday’s closing price, this would have valued these purchases at roughly $26.6 million altogether. This is only a small fraction of the total holdings. ARKG is up roughly 59% in the past year and ARKK is up 53%.
Check out all of ARK Invest’s buys for Monday:
| Fund | Ticker | Company | Shares |
|---|---|---|---|
| ARKF | ETSY | Etsy | 64,213 |
| ARKG | VERV | Verve Therapeutics | 94,600 |
| ARKG | SURF | Surface Oncology | 14,000 |
| ARKG | SMFR | Sema4 | 551,578 |
| ARKG | SGFY | Signify Health | 102,356 |
| ARKG | RPTX | Repare Therapeutics | 5,897 |
| ARKG | QSI | Quantum-Si | 70,000 |
| ARKG | PACB | Pacific Biosciences of California | 96,000 |
| ARKG | FATE | Fate Therapeutics | 27,556 |
| ARKG | CMIIU | CM Life Sciences II | 5,000 |
| ARKG | EDIT | Editas Medicine | 30,356 |
| ARKG | MASS | 908 Devices | 10,671 |
| ARKK | VCYT | Veracyte | 11,405 |
| ARKK | PD | PagerDuty | 167,000 |
| ARKK | PACB | Pacific Biosciences of California | 756,850 |
| ARKK | CRSP | CRISPR Therapeutics | 55,000 |
| ARKK | BEAM | Beam Therapeutics | 81,497 |
| ARKQ | MKFG | Markforged | 18,200 |
| ARKQ | PATH | UiPath | 283,325 |
| ARKQ | SPFR | Jaws Spitfire Acquisition | 74,000 |
| ARKQ | U | Unity Software | 166,740 |
| ARKQ | LMT | Lockheed Martin | 57,202 |
| ARKQ | IRDM | Iridium Communications | 202,159 |
| ARKQ | AVAV | AeroVironment | 15,267 |
| ARKW | VUZI | Vuzix | 99,712 |
| ARKW | PD | PagerDuty | 43,000 |
| ARKW | KVSB | Khosla Venture Acquisition II | 90,000 |
| ARKW | TWLO | Twilio | 31,572 |
| ARKW | ETSY | Etsy | 61,144 |
| ARKW | CND | Concord Acquisition | 35,000 |
| ARKX | AMZN | Amazon.com | 373 |
| ARKX | LMT | Lockheed Martin | 5,784 |
| ARKX | SPFR | Jaws Spitfire Acquisition | 16,000 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
ALSO READ: 5 Favorite Dividend-Paying Banks to Buy Now With Q2 Earnings Over
Get Our Free Investment Newsletter
Source: Read Full Article